Adicon Holdings Limited (HKG:9860)
Hong Kong
· Delayed Price · Currency is HKD 6.60
-0.32 (-4.62%)
At close: Jun 13, 2025, 4:00 PM HKT
Adicon Holdings Revenue
In the year 2024, Adicon Holdings had annual revenue of 2.91B CNY, down -11.64%. Adicon Holdings had revenue of 1.45B in the half year ending December 31, 2024, a decrease of -40.02%.
Revenue
2.91B CNY
Revenue Growth
-11.64%
P/S Ratio
1.54
Revenue / Employee
535.19K CNY
Employees
5,445
Market Cap
4.79B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.91B | -383.72M | -11.64% |
| Dec 31, 2023 | 3.30B | -1.56B | -32.15% |
| Dec 31, 2022 | 4.86B | 1.48B | 43.83% |
| Dec 31, 2021 | 3.38B | 637.78M | 23.26% |
| Dec 31, 2020 | 2.74B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines | 32.53B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| Innovent Biologics | 10.03B |
| JD Health International | 61.89B |
| WuXi Biologics | 19.87B |
| CSPC Pharmaceutical Group | 28.99B |
| Sino Biopharmaceutical | 30.72B |
| Akeso | 2.26B |